DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Chronic Condition

Idiopathic Pulmonary Fibrosis

HIGH SEVERITY

A chronic, progressive, fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults. Characterized by progressive scarring of lung tissue. Median survival 3-5 years without treatment. Associated with telomerase gene mutations in some families.

Global Affected

3.0M

Countries

15

Symptoms

Progressive dyspnea
Dry cough
Fatigue
Weight loss
Clubbing of digits
Velcro crackles on auscultation
Hypoxemia

Treatment Options

Medications
Lifestyle modifications
Physical therapy
Dietary changes
Support groups
Complementary therapies
Regular monitoring

Risk Factors

1Age
2Obesity
3Sedentary lifestyle
4Smoking
5Poor diet
6Family history
7Environmental exposures
8Stress

Diagnostic Methods

  • 1Clinical evaluation
  • 2Laboratory tests
  • 3Imaging
  • 4Functional assessments
  • 5Patient-reported outcomes
  • 6Screening questionnaires

Prognosis

Chronic conditions require ongoing management. With proper treatment and lifestyle modifications, most patients can maintain good quality of life.

Prevention

  • Healthy lifestyle
  • Regular exercise
  • Balanced diet
  • Stress management
  • Avoidance of toxins
  • Regular health screenings

Research Status

Antifibrotics nintedanib and pirfenidone slow decline in FVC. Lung transplant only definitive treatment. Triple therapy (prednisone/azathioprine/NAC) harmful. Anti-fibrotic combinations being studied.

Affected Countries

AustraliaBrazilCanadaChinaGermanySpainFranceUnited KingdomIndiaItalyJapanLTNigeriaThailandUnited States

Sources

  • https://www.who.int/chp
  • https://www.cdc.gov/chronicdisease
  • https://medlineplus.gov/chronicdiseases.html

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.